Molecular docking, synthesis and preliminary evaluation of hybrid molecules of benzothiazole cross-linked with hydroxamic acid by certain linkers as HDAC inhibitors
Open Access
- 11 October 2024
- journal article
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1212
Abstract
Background Molecular hybridization in drug design is proved to be very successful approach to provide new chemical entities with potential activities and desirable physicochemical properties. Histone deacetylases (HDACs) are involved in controlling the behavior and acetylation of histone and non-histone proteins and their inhibition causes block of cell growth, differentiation, changes in gene expression, and death. Consequently, HDAC inhibitors may lead to anticytotoxic activity. An approach of synthesizing hybrid molecules of benzothiazole cross-linked with hydroxamic acid via an amino acid or aminoalkanoic acid was considered. This approach is expected to optimize the anticytotoxic activity of the proposed compounds. Methods Hybrid molecules of benzothiazole cross-linked with hydroxamic acid (2A-E) were synthesized and their chemical structures were confirmed by spectral analyses (FT-IR, 1H-NMR and 13C-NMR). These were subjected to molecular docking on HDAC8 (PDB ID: 1T69). Computational methods were employed using the SwissADME server to predict the ADME parameters and other physicochemical properties. The cytotoxicity evaluation was performed using MTT colorimetric assay. Results Hybrids (2A-E) recorded lower ΔG (-6.322 to - 9.46) than Vorinostat (SAHA, -5.375). ΔG is an affinity scoring function (kcal/mol) and is employed to rank the candidate poses as the sum of the electrostatic and Van der Waals energies. Benzothiazole cross-linked with hydroxamic acid by a p-aminobenzoic acid (2E) has recorded the lowest docking score of -9.460 and this may refer to the possibility of high inhibitory activity. The hybrids showed no violation from Lipinski’s rule and complied with parameters with low possible passive oral absorption and no penetration into BBB. Hybrid molecules of benzothiazole recorded very interesting results, particularly, 2D and 2E which showed significant and remarkable activity. Conclusions Hybrid molecules of benzothiazole cross-linked with hydroxamic acid recorded very interesting results, particularly, compounds 2D and 2E which showed significant and remarkable activity on lung cancer cell line type A549.Keywords
Funding Information
- Department of Pharmacy, Al-Farabi University College
- College of Pharmacy, Al-Mustanseryia University
This publication has 28 references indexed in Scilit:
- New horizons in benzothiazole scaffold for cancer therapy: Advances in bioactivity, functionality, and chemistryApplied Materials Today, 2020
- Hybrid molecules with potential in vitro antiplasmodial and in vivo antimalarial activity against drug‐resistant Plasmodium falciparumMedicinal Research Reviews, 2019
- Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in OncologyDrug Safety, 2019
- Recent advances (2015–2016) in anticancer hybridsEuropean Journal of Medicinal Chemistry, 2017
- Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitroEuropean Journal of Medicinal Chemistry, 2017
- Histone deacetylases inhibitors (HDACis) as novel therapeutic application in various clinical diseasesProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2017
- Hybrid molecules: The privileged scaffolds for various pharmaceuticalsEuropean Journal of Medicinal Chemistry, 2016
- Inhibitors of histone deacetylase as antitumor agents: A critical reviewBioorganic Chemistry, 2016
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 2012
- Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agentsBioorganic & Medicinal Chemistry Letters, 2011